AskbyGeeks, May 31, 2023
Five-year risk of heart failure compared with patients not receiving anthracycline-based chemotherapy in a cohort of young adult (YA) cancer survivors diagnosed between January 2000 and January 2019 who received anthracycline-based chemotherapy Higher rates and overall higher risk of developing heart failure.